5 Free Dividend Stocks for 2022
Could these top payout stocks be part of the greatest wealth-creating tool in history?
Learn More.
Jean Jacques Bienaime, insider at BioMarin Pharmaceutical
Jean Jacques Bienaime Insider Alerts

Get notified the next time Jean Jacques Bienaime buys or sells BioMarin Pharmaceutical stock. Enter your email address below to get our daily insider buying and selling report.

Jean Jacques Bienaime Insider Information

Jean Jacques Bienaime is the chairman and CEO at BioMarin, a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases.

Bienaimé joined BioMarin in 2005 as CEO and a member of the board of directors, bringing more than 25 years of biotechnology and pharmaceutical experience. He is credited with the company’s significant growth in revenue, employees, and stature. Under his direction, BioMarin’s market capitalization went from approximately $450 million to around $14 billion. 

Prior to BioMarin, Bienaimé was the chairman, CEO, and president of Genencor, a leading biotechnology company and a pioneer in enzyme innovation.

During his tenure, the company’s revenues experienced a significant increase to more than $400 million, and in 2005, it was sold to Danisco at an enterprise value of more than $1.2 billion.

Before Genencor, Bienaimé was the chairman, CEO, and president of Sangstat Medical Corporation, where he managed revenue growth, bringing it to profitability before it was acquired by Genzyme Corporation.

Previously, he held senior management roles at Rhone-Poulenc Rorer Pharmaceuticals (now SanofiAventis), including senior vice president of worldwide marketing and business development. In this role, he was responsible for the U.S. launch of Lovenox® and the global launch of Taxotere®. He also worked for Genentech, Inc. where he was involved with the launch of tissue plasminogen activator (t-PA).

Bienaimé currently sits on the board of Incyte Corporation, as well as those of industry trade organizations, PhRMA and Biotechnology Innovation Organization (BIO). He has previously served on the boards of Portola Pharmaceuticals, Inc., InterMune, Inc., and Vital Therapies, Inc., among others. 

In 2020, he was recognized as one of The Healthcare Technology Report’s “Top 50 Healthcare Technology CEOs.”

Bienaimé earned a degree in economics at the École Supérieure de Commerce de Paris and an M.B.A. from the Wharton School at the University of Pennsylvania 

What is Jean Jacques Bienaime's net worth?

The estimated net worth of Jean Jacques Bienaime is at least $26.38 million as of May 10th, 2021. Mr. Bienaime owns 312,352 shares of BioMarin Pharmaceutical stock worth more than $26,378,126 as of January 20th. This net worth evaluation does not reflect any other investments that Mr. Bienaime may own. Learn More.

How do I contact Jean Jacques Bienaime?

The corporate mailing address for Mr. Bienaime and other BioMarin Pharmaceutical executives is 770 Lindaro Street, San Rafael CA, 94901. BioMarin Pharmaceutical can also be reached via phone at (415) 506-6700 and via email at [email protected]

Has Jean Jacques Bienaime been buying or selling shares of BioMarin Pharmaceutical?

In the last ninety days, Jean Jacques Bienaime has sold $439,300.00 in shares of BioMarin Pharmaceutical stock. Most recently, Jean Jacques Bienaime sold 5,000 shares of the business's stock in a transaction on Thursday, January 13th. The shares were sold at an average price of $87.86, for a transaction totalling $439,300.00.

Who are BioMarin Pharmaceutical's active insiders?

BioMarin Pharmaceutical's insider roster includes Jeffrey Ajer (EVP), Jean Bienaime (CEO), George Davis (EVP), Richard Meier (Director), and Brian Mueller (CFO).

Are insiders buying or selling shares of BioMarin Pharmaceutical?

In the last twelve months, insiders at the biotechnology company sold shares 22 times. They sold a total of 135,546 shares worth more than $10,892,217.87. The most recent insider tranaction occured on January, 14th when Director V Bryan Lawlis sold 4,250 shares worth more than $372,342.50. Insiders at BioMarin Pharmaceutical own 1.7 % of the company.

Information on this page was last updated on 1/14/2022.

Jean Jacques Bienaime Insider Trading History at BioMarin Pharmaceutical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/13/2022Sell5,000$87.86$439,300.00View SEC Filing Icon  
12/15/2021Sell6,000$82.71$496,260.00View SEC Filing Icon  
12/1/2021Sell1,500$87.22$130,830.00View SEC Filing Icon  
5/10/2021Sell8,513$77.29$657,969.77312,352View SEC Filing Icon  
5/7/2021Sell25,000$78.12$1,953,000.00303,839View SEC Filing Icon  
4/23/2021Sell10,000$79.34$793,400.00312,498View SEC Filing Icon  
3/11/2021Sell7,000$77.68$543,760.00295,652View SEC Filing Icon  
2/19/2021Sell7,000$83.58$585,060.00302,552View SEC Filing Icon  
2/17/2021Sell8,000$84.54$676,320.00303,552View SEC Filing Icon  
1/29/2021Sell8,334$82.67$688,971.78303,885View SEC Filing Icon  
1/27/2021Sell8,333$85.49$712,388.17303,885View SEC Filing Icon  
12/28/2020Sell1,500$88.77$133,155.00297,052View SEC Filing Icon  
5/8/2020Sell20,000$91.72$1,834,400.00318,552View SEC Filing Icon  
5/4/2020Sell5,000$88.00$440,000.00298,552View SEC Filing Icon  
5/1/2020Sell4,000$89.38$357,520.00298,552View SEC Filing Icon  
4/28/2020Sell20,000$97.58$1,951,600.00318,213View SEC Filing Icon  
4/9/2020Sell10,000$79.06$790,600.00308,213View SEC Filing Icon  
3/9/2020Sell10,000$89.52$895,200.00296,443View SEC Filing Icon  
1/14/2020Sell8,000$87.95$703,600.00335,530View SEC Filing Icon  
1/7/2020Sell3,000$84.46$253,380.00330,530View SEC Filing Icon  
12/27/2019Sell5,000$86.16$430,800.00View SEC Filing Icon  
11/22/2019Sell10,000$77.60$776,000.00327,070View SEC Filing Icon  
10/25/2019Sell5,000$69.55$347,750.00332,520View SEC Filing Icon  
5/10/2019Sell10,000$82.52$825,200.00336,520View SEC Filing Icon  
5/8/2019Sell4,000$82.16$328,640.00326,520View SEC Filing Icon  
4/26/2019Sell3,000$82.88$248,640.00329,211View SEC Filing Icon  
4/12/2019Sell4,000$89.12$356,480.00325,211View SEC Filing Icon  
4/8/2019Sell3,000$91.87$275,610.00327,211View SEC Filing Icon  
4/5/2019Sell3,000$93.37$280,110.00327,211View SEC Filing Icon  
3/25/2019Sell4,000$87.86$351,440.00323,211View SEC Filing Icon  
3/15/2019Sell4,000$94.40$377,600.00300,558View SEC Filing Icon  
3/12/2019Sell9,000$90.06$810,540.00333,701View SEC Filing Icon  
3/7/2019Sell4,000$90.78$363,120.00332,701View SEC Filing Icon  
2/27/2019Sell4,000$91.78$367,120.00292,290View SEC Filing Icon  
2/21/2019Sell3,000$90.12$270,360.00291,290View SEC Filing Icon  
2/14/2019Sell4,000$95.20$380,800.00292,290View SEC Filing Icon  
2/5/2019Sell4,000$98.63$394,520.00292,290View SEC Filing Icon  
1/22/2019Sell3,000$96.82$290,460.00291,290View SEC Filing Icon  
1/14/2019Sell4,000$93.79$375,160.00292,290View SEC Filing Icon  
1/10/2019Sell3,000$90.55$271,650.00291,290View SEC Filing Icon  
1/7/2019Sell3,000$87.58$262,740.00291,290View SEC Filing Icon  
12/28/2018Sell3,000$84.04$252,120.00View SEC Filing Icon  
12/28/2018Sell3,000$84.04$252,120.00291,290View SEC Filing Icon  
12/26/2018Sell4,000$80.50$322,000.00292,290View SEC Filing Icon  
12/14/2018Sell2,000$92.64$185,280.00290,290View SEC Filing Icon  
12/12/2018Sell2,000$93.12$186,240.00290,290View SEC Filing Icon  
11/1/2018Sell4,000$92.55$370,200.00292,290View SEC Filing Icon  
10/3/2018Sell1,500$99.36$149,040.00287,790View SEC Filing Icon  
9/4/2018Sell1,500$98.16$147,240.00286,790View SEC Filing Icon  
7/23/2018Sell1,500$101.69$152,535.00286,790View SEC Filing Icon  
5/17/2018Sell18,750$88.66$1,662,375.00309,350View SEC Filing Icon  
5/15/2018Sell37,500$88.75$3,328,125.00309,350View SEC Filing Icon  
5/11/2018Sell18,750$88.42$1,657,875.00View SEC Filing Icon  
4/24/2018Sell20,000$82.43$1,648,600.00300,031View SEC Filing Icon  
4/20/2018Sell10,000$83.65$836,500.00300,031View SEC Filing Icon  
3/15/2018Sell15,000$84.73$1,270,950.00279,674View SEC Filing Icon  
2/15/2018Sell10,000$84.63$846,300.00View SEC Filing Icon  
1/5/2018Sell10,000$90.32$903,200.00235,894View SEC Filing Icon  
12/29/2017Sell20,000$89.75$1,795,000.00View SEC Filing Icon  
12/29/2017Sell10,000$89.61$896,100.00226,494View SEC Filing Icon  
6/5/2017Sell10,000$90.13$901,300.00238,564View SEC Filing Icon  
5/24/2017Sell5,000$88.38$441,900.00238,564View SEC Filing Icon  
5/17/2017Sell5,000$91.73$458,650.00238,564View SEC Filing Icon  
5/8/2017Sell10,000$96.09$960,900.00238,496View SEC Filing Icon  
4/27/2017Sell5,000$95.72$478,600.00243,194View SEC Filing Icon  
4/25/2017Sell5,000$94.00$470,000.00243,194View SEC Filing Icon  
3/16/2017Sell10,000$91.69$916,900.00211,364View SEC Filing Icon  
3/10/2017Sell11,000$90.59$996,490.00212,364View SEC Filing Icon  
1/26/2017Sell10,000$84.22$842,200.00175,682View SEC Filing Icon  
1/11/2017Sell8,000$90.58$724,640.00174,682View SEC Filing Icon  
1/9/2017Sell8,000$88.49$707,920.00174,682View SEC Filing Icon  
12/30/2016Sell8,000$83.60$668,800.00174,682View SEC Filing Icon  
11/22/2016Sell69,743$85.69$5,976,277.67View SEC Filing Icon  
11/21/2016Sell69,744$87.56$6,106,784.64View SEC Filing Icon  
11/8/2016Sell140,000$82.67$11,573,800.00393,368View SEC Filing Icon  
11/7/2016Sell70,000$82.52$5,776,400.00393,368View SEC Filing Icon  
10/28/2016Sell120,000$81.30$9,756,000.00383,368View SEC Filing Icon  
10/17/2016Sell41,666$84.39$3,516,193.74365,034View SEC Filing Icon  
10/14/2016Sell64,125$86.96$5,576,310.00378,184View SEC Filing Icon  
9/29/2016Sell53,125$93.65$4,975,156.25431,709View SEC Filing Icon  
9/16/2016Sell137,368$95.34$13,096,665.12421,161View SEC Filing Icon  
8/16/2016Sell41,666$91.49$3,812,022.34420,250View SEC Filing Icon  
7/18/2016Sell41,666$92.72$3,863,271.52420,250View SEC Filing Icon  
6/16/2016Sell41,666$80.55$3,356,196.30420,250View SEC Filing Icon  
5/5/2016Sell50,000$80.15$4,007,500.00390,156View SEC Filing Icon  
5/2/2016Sell36,500$85.01$3,102,865.00395,635View SEC Filing Icon  
3/1/2016Sell10,000$84.28$842,800.00350,500View SEC Filing Icon  
11/30/2015Sell1,000$94.74$94,740.00228,754View SEC Filing Icon  
10/15/2015Sell1,000$108.24$108,240.00228,754View SEC Filing Icon  
9/14/2015Sell1,000$131.43$131,430.00228,754View SEC Filing Icon  
7/7/2015Sell1,500$139.07$208,605.00View SEC Filing Icon  
3/17/2015Sell2,000$124.17$248,340.00View SEC Filing Icon  
3/16/2015Sell1,000$123.48$123,480.00View SEC Filing Icon  
3/10/2015Sell21,021$112.39$2,362,550.19View SEC Filing Icon  
3/9/2015Sell19,000$112.13$2,130,470.00View SEC Filing Icon  
3/5/2015Sell10,000$113.70$1,137,000.00View SEC Filing Icon  
3/4/2015Sell13,916$107.92$1,501,814.72View SEC Filing Icon  
3/3/2015Sell5,000$107.42$537,100.00View SEC Filing Icon  
3/2/2015Sell5,000$108.44$542,200.00View SEC Filing Icon  
1/9/2015Sell2,000$94.14$188,280.00View SEC Filing Icon  
12/24/2014Sell5,000$88.73$443,650.00View SEC Filing Icon  
12/10/2014Sell2,000$95.00$190,000.00View SEC Filing Icon  
11/25/2014Sell2,000$90.00$180,000.00View SEC Filing Icon  
11/12/2014Sell1,000$81.51$81,510.00View SEC Filing Icon  
11/10/2014Sell4,000$87.00$348,000.00View SEC Filing Icon  
11/3/2014Sell3,000$85.33$255,990.00View SEC Filing Icon  
10/24/2014Sell2,000$80.00$160,000.00View SEC Filing Icon  
8/20/2014Sell5,000$70.00$350,000.00View SEC Filing Icon  
6/4/2014Sell2,000$61.20$122,400.00View SEC Filing Icon  
5/22/2014Sell1,000$56.88$56,880.00180,257View SEC Filing Icon  
5/21/2014Sell1,545$56.19$86,813.55180,257View SEC Filing Icon  
12/24/2013Sell10,000$68.71$687,100.00View SEC Filing Icon  
12/5/2013Sell5,000$69.70$348,500.00View SEC Filing Icon  
10/16/2013Sell2,000$67.73$135,460.00View SEC Filing Icon  
10/10/2013Sell3,000$66.76$200,280.00View SEC Filing Icon  
9/16/2013Sell2,000$73.08$146,160.00View SEC Filing Icon  
8/15/2013Sell1,000$64.36$64,360.00View SEC Filing Icon  
5/21/2013Sell2,000$64.14$128,280.00View SEC Filing Icon  
5/16/2013Sell12,000$67.90$814,800.00View SEC Filing Icon  
5/14/2013Sell15,000$70.17$1,052,550.00View SEC Filing Icon  
5/13/2013Sell15,800$68.77$1,086,566.00View SEC Filing Icon  
5/8/2013Sell4,000$65.87$263,480.00View SEC Filing Icon  
5/2/2013Sell3,000$64.99$194,970.00View SEC Filing Icon  
2/4/2013Sell2,000$55.77$111,540.00View SEC Filing Icon  
12/27/2012Sell17,000$48.37$822,290.00View SEC Filing Icon  
See Full Table

Jean Jacques Bienaime Buying and Selling Activity at BioMarin Pharmaceutical

This chart shows Jean Jacques Bienaime's buying and selling at BioMarin Pharmaceutical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioMarin Pharmaceutical Company Overview

BioMarin Pharmaceutical logo
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.
Read More

Today's Range

Now: $84.45
Low: $84.26
High: $87.49

50 Day Range

MA: $86.67
Low: $80.74
High: $91.47

2 Week Range

Now: $84.45
Low: $71.59
High: $92.17


863,821 shs

Average Volume

1,564,464 shs

Market Capitalization

$15.50 billion

P/E Ratio


Dividend Yield



Grow Your Retirement Account With This Trade!
Whether you’re close to retirement or have barely begun your career, "How To Master the Retirement Trade" by expert Dave Aquino is the guide you’ve been waiting for.

Take advantage of a little known trade window and watch retirement come sooner than you ever thought possible.
Get your copy now!